Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart

American Journal of Physiology - Cell Physiology

Volumn 307, Issue 6, 2014, Pages C499-C507

  Pham, Toan ^a   Loiselle, Denis ^b,c   Power, Amelia ^a   Hickey, Anthony J R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

ATP flux; Mitochondrial efficiency; Mitochondrial membrane potential; Mitochondrial reactive oxygen species production

Indexed keywords

ADENOSINE TRIPHOSPHATE; CITRATE SYNTHASE; GLUCOSE; OXYGEN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; ARTICLE; BIOENERGY; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; FLUOROMETER; GLUCOSE BLOOD LEVEL; HEART MITOCHONDRION; HYDROLYSIS; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN TRANSPORT; PREDICTIVE VALUE; RAT; RESPIROMETER; STEADY STATE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; ATP FLUX; CELL RESPIRATION; CHEMICALLY INDUCED DISORDER; ENERGY METABOLISM; EXPERIMENTAL DIABETES MELLITUS; HEART MUSCLE; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MITOCHONDRIAL EFFICIENCY; MITOCHONDRIAL REACTIVE OXYGEN SPECIES PRODUCTION; OXIDATIVE STRESS; SPECTROFLUOROMETRY; SPRAGUE DAWLEY RAT; TIME;

ATP FLUX; MITOCHONDRIAL EFFICIENCY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL REACTIVE OXYGEN SPECIES PRODUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANOXIA; CELL RESPIRATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC CARDIOMYOPATHIES; ENERGY METABOLISM; HYDROLYSIS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; MYOCARDIUM; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PROTON-TRANSLOCATING ATPASES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SPECTROMETRY, FLUORESCENCE; TIME FACTORS;

EID: 84907149453     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00006.2014     Document Type: Article

References (68)

1. Aasum E, Belke D, Severson D, Riemersma R, Cooper M, Andreassen M, Larsen TS. Cardiac function and metabolism in type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR activator. Am J Physiol Heart Circ Physiol 283: H949–H957, 2002.
2. Anderson E, Kypson A, Rodriguez E, Anderson C, Lehr E, Neufer P. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol 54: 1891–1898, 2009.
3. Andreyev AY, Kushnareva YE, Starkov AA. Mitochondrial metabolism of reactive oxygen species. Biochem (Mosc) 70: 200–214, 2005.
4. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 26: 195–220, 1995.
5. Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 38: 1278–1295, 2005.
6. Barth E, Stammler G, Speiser B, Schaper J. Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. J Mol Cell Cardiol 24: 669–681, 1992.
7. Belke DD, Swanson EA, Dillmann WH. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53: 3201–3208, 2004.
8. Bella JN, Devereux RB, Roman MJ, Palmieri V, Liu JE, Paranicas M, Welty TK, Lee ET, Fabsitz RR, Howard B., Strong Heart Study Investigators. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol 87: 1260–1265, 2001.
9. Benard G, Faustin B, Passerieux E, Galinier A, Rocher C, Bellance N, Delage JP, Casteilla L, Letellier T, Rossignol R. Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol 291: C1172–C1182, 2006.
10. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 115: 3213–3223, 2007.
11. Boudina S, Abel ED. Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology 21: 250–258, 2006.
12. Boudina S, Sena S, O’Neill BT, Tathireddy P, Young ME, Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112: 2686–2695, 2005.
13. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED, Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED. Mitochondrial energetics in the heart in obesityrelated diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56: 2457–2466, 2007.
14. Brand MD. The efficiency and plasticity of mitochondrial energy transduction. Biochem Soc Trans 33: 897–904, 2005.
15. Brand MD, Harper ME, Taylor HC. Control of the effective P/O ratio of oxidative phosphorylation in liver mitochondria and hepatocytes. Biochem J 291: 739–748, 1993.
16. Brown GC. Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem J 284: 1–13, 1992.
17. Bugger H, Abel ED. Mitochondria in the diabetic heart. Cardiovasc Res 88: 229–240, 2010.
18. Bugger H, Boudina S, Hu XX, Tuinei J, Zaha VG, Theobald HA, Yun UJ, McQueen AP, Wayment B, Litwin SE, Abel ED. Type 1 diabetic Akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes 57: 2924–2932, 2008.
19. Cameron VA, Faatoese AF, Gillies MW, Robertson PJ, Huria TM, Doughty RN, Whalley GA, Richards MA, Troughton RW, Tikao- Mason KN, Wells EJ, Sheerin IG, Pitama SG. A cohort study comparing cardiovascular risk factors in rural Maori, urban Maori and non-Maori communities in New Zealand. BMJ Open 2, 2012.
20. Chinopoulos C, Vajda S, Csanady L, Mandi M, Mathe K, Adam-Vizi V. A novel kinetic assay of mitochondrial ATP-ADP exchange rate mediated by the ANT. J Biophys 96: 2490–2504, 2009.
21. Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 25–28, 1997.
22. Devereux R, Roman M, Paranicas M, O’Grady M, Lee E, Welty T, Fabsitz R, Robbins D, Rhoades E, Howard B. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 101: 2271–2276, 2000.
23. Dorn GW, Maack C. SR and mitochondria: calcium cross-talk between kissing cousins. J Mol Cell Cardiol 2: 2, 2012.
24. Duchen MR. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med 25: 365–451, 2004.
25. Dufour S, N, Rousse N, Canioni P, Diolez P. Top-down control analysis of temperature effect on oxidative phosphorylation. Biochem J 314: 743–751, 1996.
26. Duncan JG. Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 1813: 1351–1359, 2011.
27. Duncan JG, Fong JL, Medeiros DM, Finck BN, Kelly DP. Insulinresistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-/PGC-1 gene regulatory pathway. Circulation 115: 909–917, 2007.
28. Figueira TR, Melo DR, Vercesi AE, Castilho RF. Safranine as a fluorescent probe for the evaluation of mitochondrial membrane potential in isolated organelles and permeabilized cells. Methods Mol Cell Biol 810: 103–117, 2012.
29. Gledhill JR, Montgomery MG, Leslie AG, Walker JE. How the regulatory protein, IF1, inhibits F1-ATPase from bovine mitochondria. Proc Natl Acad Sci USA 104: 15671–15676, 2007.
30. Gnaiger E. Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int J Biochem Cell Biol 41: 1837–1845, 2009.
31. Gnaiger E. Mitochondrial Pathways and Respiratory Control. Innsbruck, Austria: Oxoboros, 2011.
32. Gnaiger E. Mitochondrial Pathways and Respiratory Control (1st ed.), edited by Gnaiger E. Innsbruck, Austria: OROBOROS MiPNet, 2007.
33. Gnaiger E. Oxygen conformance of cellular respiration: a perspective of mitochondrial physiology. In: Hypoxia: Through the Lifecycle, edited by Roach RC, et al. New York: Kluwer Academic/Plenum, 2003, chapt. 3.
34. Gnaiger E. Polarographic Oxygen Sensors, the Oxygraph and High- Resolution Respirometry to Assess Mitochondrial Function. New York: Wiley, 2008.
35. Gnaiger E, Lassnig B, Kuznetsov A, Rieger G, Margreiter R. Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase. J Exp Biol 201: 1129–1139, 1998.
36. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127: 143–152, 2013.
37. Goo S, Pham T, Han JC, Nielsen P, Taberner A, Hickey A, Loiselle DS. Multiscale measurement of cardiac energetics. Clin Exp Pharmacol Physiol 44: 2013–2003, 2013.
38. Han JC, Tran K, Nielsen PM, Taberner AJ, Loiselle DS. Streptozotocin- induced diabetes prolongs twitch duration without affecting the energetics of isolated ventricular trabeculae. Cardiovasc Diabetol 13: 79, 2014.
39. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 107: 539–557, 2004.
40. Herlein JA, Fink BD, O’Malley Y, Sivitz WI. Superoxide and respiratory coupling in mitochondria of insulin-deficient diabetic rats. Endocrinology 150: 46–55, 2009.
41. Hickey AJ, Renshaw GM, Speers-Roesch B, Richards JG, Wang Y, Farrell AP, Brauner CJ. A radical approach to beating hypoxia: depressed free radical release from heart fibres of the hypoxia-tolerant epaulette shark (Hemiscyllum ocellatum). J Comp Physiol B 182: 91–100, 2012.
42. Hickey AJ, Chai CC, Choong SY, Costa SF, Skea GL, Phillips AR, Cooper G.. Impaired ATP turnover and ADP supply depress cardiac mitochondrial respiration and elevate superoxide in nonfailing spontaneously hypertensive rat hearts. Am J Physiol Cell Physiol 297: C766–C774, 2009.
43. Jullig M, Hickey A, Middleditch M, Crossman D, Lee S, Cooper G. Characterization of proteomic changes in cardiac mitochondria in streptozotocin- diabetic rats using iTRAQ isobaric tags. J Proteomics Clin Appl 1: 565–576, 2007.
44. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995– 2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414–1431, 1998.
45. Kingsley-Hickman PB, Sako EY, Ugurbil K, From AH, Foker JE. 31P NMR measurement of mitochondrial uncoupling in isolated rat hearts. J Biol Chem 265: 1545–1550, 1990.
46. Kjaerulf-Jensen H, Korsgaard N, Lindeberg H, Vigholt-Sørensen E. Myocardial ultrastructure in the isolated rabbit heart exposed to dopamine, dobutamine, isoprenaline, G-strofanthin, xamoterol and hypoxia. Pharmacol Toxicol 71: 302–304, 1992.
47. Kovacs M, Toth J, Hetenyi C, Malnasi-Csizmadia A, Sellers JR. Mechanism of blebbistatin inhibition of myosin II. J Biochem 279: 35557–35563, 2004.
48. Larsen S, Nielsen J, Hansen CN, Nielsen LB, Wibrand F, Stride N, Schroder HD, Boushel R, Helge JW, Dela F, Hey-Mogensen M. Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. Physiology 590: 3349–3360, 2012.
49. Lee CP, Gu Q, Xiong Y, Mitchell RA, Ernster L. P/O ratios reassessed: mitochondrial P/O ratios consistently exceed 1.5 with succinate and 25 with NAD-linked substrates. FASEB J 10: 345–350, 1996.
50. Lemieux M, Semsroth S, Antretter H, Höfer D, Gnaiger E. Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int J Biochem Cell B 43: 1729–1738, 2011.
51. MacDonald JR, Oellermann M, Rynbeck S, Chang G, Ruggiero K, Cooper G., Hickey AJ. Transmural differences in respiratory capacity across the rat left ventricle in health, aging, and streptozotocin-induced diabetes mellitus: evidence that mitochondrial dysfunction begins in the subepicardium. Am J Physiol Cell Physiol 300: C246–C255, 2011.
52. Murphy M. How mitochondria produce reactive oxygen species. Biochem J 417: 1–13, 2009.
53. Newsholme EA, Crabtree B. Maximum catalytic activity of some key enzymes in provision of physiologically useful information about metabolic fluxes. J Exp Zool 239: 159–167, 1986.
54. Palmieri V, Bella JN, Arnett DR, Liu JE, Oberman A, Schuck MY, Kitzman DW, Hopkins PN, Morgan D, Rao DC, Devereux RB. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) Study. Circulation 103: 102–107, 2001.
55. Parks RE, Adler J, Copenhaver JH. The efficiency of oxidative phosphorylation in mitochondria from diabetic rats. J Biol Chem 214: 693–698, 1955.
56. Patel HH, McDonough AA. Of mice and men: modeling cardiovascular complexity in diabetes. Focus on “Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart.” Am J Physiol Cell Physiol (July 16, 2014). doi:10.1152/ajpcell.00241.2014.
57. Paulson DJ. The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 34: 104–112, 1997.
58. Pesta D, Gnaiger E. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Cell Biol 810: 25–58, 2012.
59. Pierce GN, Dhalla N. Heart mitochondrial function in chronic experimental diabetes in rats. Can J Cardiol 1: 48–54, 1985.
60. Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 77: 731–758, 1997.
61. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212: 167-178, 2006.
62. Rottenberg H. Membrane potential and surface potential in mitochondria: uptake and binding of lipophilic cations. J Membr Biol 81: 127–138, 1984.
63. Rubler S, Dlugash J, Yuceoglu Y, Kumral T, Branwood A, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30: 595–602, 1972.
64. Shen X, Zheng S, Thongboonkerd V, Xu M, Pierce WM Jr, Klein JB, Epstein PN. Cardiac mitochondrial damage and biogenesis in a chronic model of type I diabetes. Am J Physiol Endocrinol Metab 287: E896–E905, 2004.
65. Speakman JR, Talbot DA, Selman C, Snart S, McLaren JS, Redman P, Krol E, Jackson DM, Johnson MS, Brand MD. Uncoupled and surviving: individual mice with high metabolism have greater mitochondrial uncoupling and live longer. Aging Cell 3: 87–95, 2004.
66. Srere P. Citrate synthase. Methods Enzymol 13, 1969.
67. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, Saks VA. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta 892: 191–196, 1987.
68. Zukiene R, Nauciene Z, Ciapaite J, Mildaziene V. Acute temperature resistance threshold in heart mitochondria: febrile temperature activates function but exceeding it collapses the membrane barrier. Int J Hyperthermia 26: 56–66, 2010.